GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Charmacy Pharmaceutical Co Ltd (HKSE:02289) » Definitions » Gross-Profit-to-Asset %

Charmacy Pharmaceutical Co (HKSE:02289) Gross-Profit-to-Asset % : 9.21% (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Charmacy Pharmaceutical Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Charmacy Pharmaceutical Co's annualized Gross Profit for the quarter that ended in Dec. 2024 was HK$332 Mil. Charmacy Pharmaceutical Co's average Total Assets over the quarter that ended in Dec. 2024 was HK$3,606 Mil. Therefore, Charmacy Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 9.21%.


Charmacy Pharmaceutical Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Charmacy Pharmaceutical Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charmacy Pharmaceutical Co Gross-Profit-to-Asset % Chart

Charmacy Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.34 8.67 9.22 9.48 9.57

Charmacy Pharmaceutical Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.45 9.89 9.89 10.30 9.21

Competitive Comparison of Charmacy Pharmaceutical Co's Gross-Profit-to-Asset %

For the Medical Distribution subindustry, Charmacy Pharmaceutical Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charmacy Pharmaceutical Co's Gross-Profit-to-Asset % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Charmacy Pharmaceutical Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Charmacy Pharmaceutical Co's Gross-Profit-to-Asset % falls into.


;
;

Charmacy Pharmaceutical Co Gross-Profit-to-Asset % Calculation

Charmacy Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=346.74/( (3552.218+3690.562)/ 2 )
=346.74/3621.39
=9.57 %

Charmacy Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=332.212/( (3520.999+3690.562)/ 2 )
=332.212/3605.7805
=9.21 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Charmacy Pharmaceutical Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Charmacy Pharmaceutical Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Charmacy Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 235, Song Shan North Road, Longhu District, Guangdong Province, Shantou, CHN, 515041
Charmacy Pharmaceutical Co Ltd is a China-based pharmaceutical distributor. It distributes Western medicine, Chinese patent medicine, and healthcare products to downstream distributors and retail terminals while conducting dealings in the third-party logistics business of medicines and providing pharmaceutical products-related consulting services. The company's distribution network covers Southern China and surrounding areas including Fujian province. All the group's operations are located in China.
Executives
Jiangxi Pharmaceutical Investment Co., Limited 2101 Beneficial owner
Jiang Yao Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Jiang Xi Jiang Zhong Yi Yao Shang Ye Yun Ying You Xian Ze Ren Gong Si 2201 Interest of corporation controlled by you
Yao Chuanglong 2101 Beneficial owner
You Zeyan 2202 Interest of your spouse
Guang Zhou Bai Yun Shan Yi Yao Ji Tuan Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Guang Zhou Yi Yao Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Guang Yao Bai Yun Shan Xiang Gang You Xian Gong Si 2101 Beneficial owner
Rays Capital Partners Limited 2102 Investment manager
Ruan David Ching Chi 2201 Interest of corporation controlled by you
Asian Equity Special Opportunities Portfolio Master Fund Limited 2101 Beneficial owner
Wang Yonghui 2101 Beneficial owner

Charmacy Pharmaceutical Co Headlines

No Headlines